Lack of cable pili expression by cblA-containing Burkholderia cepacia complex.
暂无分享,去创建一个
J. Lipuma | John J LiPuma | Umadevi Sajjan | Janet Forstner | Lixia Liu | Annie Lu | Theodore Spilker | U. Sajjan | J. Forstner | Annie Lu | T. Spilker | Lixia Liu
[1] R. Goldstein,et al. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers , 1995, Journal of bacteriology.
[2] J. Lipuma,et al. BURKHOLDERIA CEPACIA: Management Issues and New Insights , 1998 .
[3] M. Kaufmann,et al. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. , 1996, Journal of medical microbiology.
[4] M. Dodd,et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis , 1993, The Lancet.
[5] D H Persing,et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.
[6] J. Lipuma,et al. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. , 2001, American journal of respiratory and critical care medicine.
[7] M. Whiteford,et al. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. , 1995, Thorax.
[8] M. Riley,et al. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain , 1995, Nature Medicine.
[9] H. Denk,et al. Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. , 1981, Journal of molecular biology.
[10] S. Tyler,et al. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping , 1994, Journal of clinical microbiology.
[11] R. Coutts,et al. Incidence of the cblA major subunit pilin gene amongst Burkholderia species. , 2001, FEMS microbiology letters.
[12] Tom Coenye,et al. Taxonomy and Identification of the Burkholderia cepacia Complex , 2001, Journal of Clinical Microbiology.
[13] J. Parke,et al. Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains. , 2001, Annual review of phytopathology.
[14] D. Simpson,et al. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis , 1997, Journal of clinical microbiology.
[15] D. Auble,et al. Promoter recognition by Escherichia coli RNA polymerase. Influence of DNA structure in the spacer separating the -10 and -35 regions. , 1988, Journal of molecular biology.
[16] F. K. Graaf,et al. Organization and expression of genes involved in the biosynthesis of K99 fimbriae , 1984, Infection and immunity.
[17] P. Vandamme,et al. Development of rRNA-Based PCR Assays for Identification of Burkholderia cepacia Complex Isolates Recovered from Cystic Fibrosis Patients , 1999, Journal of Clinical Microbiology.
[18] P. Vandamme,et al. DNA-Based Diagnostic Approaches for Identification of Burkholderia cepacia Complex, Burkholderia vietnamiensis, Burkholderia multivorans,Burkholderia stabilis, and Burkholderia cepacia Genomovars I and III , 2000, Journal of Clinical Microbiology.
[19] F. Sylvester,et al. Cable-Piliated Burkholderia cepaciaBinds to Cytokeratin 13 of Epithelial Cells , 2000, Infection and Immunity.
[20] M. Corey,et al. Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada , 2002, Emerging infectious diseases.
[21] L. Shimkets,et al. Genetic Structure of a Lotic Population ofBurkholderia , 1995 .
[22] P. Vandamme,et al. Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex , 2000, Journal of Clinical Microbiology.
[23] Cameron Ackerley,et al. Interaction of cblA/adhesin‐positive Burkholderia cepacia with squamous epithelium , 2002, Cellular microbiology.
[24] A. Cravioto,et al. Hemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli isolated from humans , 1982, Infection and immunity.
[25] U. Sajjan,et al. Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. , 2000, Journal of medical microbiology.
[26] D. Auble,et al. Promoter recognition by Escherichia coli RNA polymerase. Effects of substitutions in the spacer DNA separating the -10 and -35 regions. , 1986, The Journal of biological chemistry.
[27] J. Lipuma,et al. Commercial use of Burkholderia cepacia. , 1999, Emerging infectious diseases.
[28] J. Lipuma,et al. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. , 2001, The Journal of pediatrics.
[29] J. Forstner,et al. Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis , 1992, Infection and immunity.
[30] M. Kaufmann,et al. Distribution of Genes Encoding Putative Transmissibility Factors among Epidemic and Nonepidemic Strains ofBurkholderia cepacia from Cystic Fibrosis Patients in the United Kingdom , 2000, Journal of Clinical Microbiology.